Tyler Mayes, OD
Optometrist · Central City, KYNPI 1053609420
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $316 of the $355 with a category attached, or 89.1%. 7 manufacturers reported payments, led by Coopervision Inc. at 30.0% of the total. Reporting peaked in 2020 at $124 and has fallen 68.6% since, to $39 in 2025. That places this record below the midpoint for optometrist clinicians in KY, where the typical reported total is $711.
Across 16 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$106
- Johnson & Johnson Vision Care, Inc.$85
- Bausch & Lomb Americas Inc.$48
- ABB Con-cise Optical Group LLC$44
- Carl Zeiss Meditec AG$39
- Eyevance Pharmaceuticals LLC$20
- plus $12 from 1 others
What the payments were for
- Food & beverage$31689%
- Gifts$3911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$355 in reported general payments places this provider in the 30th percentile of 712 optometrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 30 | $17,751 |
| CombiganBrimonidine Tartrate/Timolol | 32 | $10,319 |
| RocklatanNetarsudil Mesylat/Latanoprost | 13 | $6,901 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 33 | $2,945 |
| Brimonidine Tartrate | 21 | $2,883 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $2,163 |
| Latanoprost | 144 | $1,188 |
| Prednisolone Acetate | 29 | $1,080 |
| Difluprednate | 12 | $1,024 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 80 | $896 |
| Timolol Maleate | 48 | $552 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 40 | $398 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Central City
- Paul KarpeckiLexington$3.6M
- Bilal AhmadLexington$150K
- Clay MattsonNicholasville$93K
- Ben LeonardCalvert City$75K
- Lee PeplinskiLouisville$74K
- Austin LifferthLouisville$72K
- Christopher KucLexington$52K
- Kristine Kerestan GarbigWilder$51K
- Renee ReederPikeville$27K
- Karoline MunsonFrankfort$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.